References
- Santoro N, Filikori M, Crowley Jr WF. Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. Endocr Rev 1986;7:11–23
- Reame NE, Sauder ED, Case GD, et al. Pulsatile gonadotropin secretion in women with hypo-thalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovula-tio n. J Clin Endocrinol Metab 1985;61:851–8
- Crowley Jr WF, Filikori M, Spratt DI, et al. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 1985;41:473–531
- Santoro N, Elzahr D. Pulsatile gonadotropin-releasing hormone therapy for ovulatory disorders. Clin Obstet Gynecol 1993;36;727–36
- Filikori M, Flamigni C, Dellai P, et al. Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J Clin Endocrinol Metab 1994;79: 1215–20
- Valk TW, Corley KP, Kelch RP, et al. Hypo-gonadotropic hypogonadism: hormonal responses to low dose administration of gonadotropin-releasing hormone. J Clin Endocrinol Metab 1988; 51:730–8
- Zucchini S, Di Natale B, Ambrosetto P, et al. Role of magnetic resonance imaging in hypothalamic-pituitary disorders. Horm Res 1995; 44(Suppl 3): 8–14
- Shah P, Patkar D, Patankar T, et al. MRI imaging features in hypothalamic hamartoma: a report of three cases and review of literature. J Postgrad Med 1999;45:84–6
- Arita K, Ikawa F, Kurisu K, et al. The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamar-toma. J Neurosurg 1999;91:212–20
- Chong BW, Newton TH. Hypothalamic and pituitary pathology. Radio/ Clin North Am 1993; 31:1147–53
- Lalich RA, Aiman J. Pituitary sarcoidosis causing secondary amenorrhea. A case report. J Reprod Med 1990;357:737–40
- Jawadi MH, Hanson TJ, Schemmel JE, et al. Hypo-thalamic sarcoidosis and hypopituitarism. Horm Res 1980;12:1–9
- Ober KP, Alexander E Jr, Ghana VR, et al. Histio-cytosis X of the hypothalamus. Neurosurgery 1989; 24:93–5
- Sawhny BS, Dohn DF. Neuroendocrinological aspects of histiocytosis X of the central nervous system. Surg Neurol 1980;14:237–9
- Isoo A, Ueki K, Ishida T, et al. Langerhans cell histiocytosis limited to the pituitary-hypothalamic axis — two case reports. Neurol Med Chir (Tokyo) 2000;40:532–5
- Martin KA, Hall JE, Adams JM, et al. Compari-son of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 1993;77:125–9
- Leger J, Velasquez A, Garel C, et al. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus. J Clin Endocrinol Metab 1999;84:1954–60
- Marci R, Dessole S, Senn A, et al. Follow-up of 32 hypothalamo-hypopituitary patients treated with pulsatile gonadotropin-releasing hormone or human menopausal gonadotropins. Gynecol Endo-crinol 1999;13:375–81
- Schenker JG, Weinstein D. Ovarian hyp erstimula-tion syndrome: a current survey. Fertil Steril 1978; 30:255–68
- SchoemakerJ. The role of the GnRH dose and the route of administration on treatment outcome and complications. Eur J Obstet Gynecol Reprod Biol 1996;65(Suppl):S13–16
- Riolo A, Carioni E, Lerro S, et al. Induction of ovulation with pulsatile GnRH: comparison between subcutaneous and intravenous administra-tion in the same patients. Acta Eur Fertil 1987;18: 271–5
- De Boer JA, Van der Meer M, Van der Veen EA, et al. GH substitution in hypogonadotropic, GH-deficient women decreases the follicle-stimulating hormone threshold for monofollicular growth. J Clin Endocrinol Metab 1999;84:590–5
- Sueldo CE, Swanson JA. The economics of inducing ovulation with human menopausal gonadotropins versus pulsatile subcutaneous go nadotropin-releasing hormone. Fertil Steril 1986; 45:128–9